Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Merck
Medtronic
Express Scripts
Harvard Business School

Last Updated: January 19, 2022

DrugPatentWatch Database Preview

Abbvie Inc Company Profile


Email this page to a colleague

« Back to Dashboard

Biologic Drugs for Abbvie Inc

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Patent Expiration
Abbvie Inc. SURVANTA beractant Suspension 020032 1991-07-01 ⤷  Try it Free
Abbvie Inc. CREON pancrelipase Capsule, Delayed Release 020725 2009-04-30 ⤷  Try it Free
Abbvie Inc. HUMIRA adalimumab Injection 125057 2002-12-31 6,805,686 ⤷  Try it Free
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Companies are sometimes listed under multiple names.
This search can help find similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Colorcon
Johnson and Johnson
Dow
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.